Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Assembly Biosciences, Inc. (ASMB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Assembly Biosciences, Inc. (ASMB), most recent 12 months reported: revenue $74.84M, net loss $42K, free cash flow -$38.57M. Latest balance sheet on file: liquid cash $320.36M. From SEC filings. Others in Pharmaceutical Preparations: Verastem, Inc. · Standard BioTools Inc. · ADC Therapeutics SA · KURA ONCOLOGY, INC. · Viridian Therapeutics, Inc./DE · ROCKWELL MEDICAL, INC. · Fortress Biotech, Inc. · Journey Medical Corp

Stock screener

Watchlist